The DNA Risk: HLA-Related Autoimmunity test requires a BloodSpot sample to provide insights related to genetic factors. This test does not accept Buccal Swab samples, ensuring that the analysis is based on the most reliable sample type. BloodSpot samples enable accurate assessment while maintaining ease of collection and transport. The collection process is straightforward and designed for convenience at home or within a clinical setting.

This test offers a scientific approach to understanding personal genetic markers associated with immune system function, which may be of interest for wellness and lifestyle considerations. By analysing specific genetic information, the test supports individuals seeking to explore their biological background and potential predispositions related to general health and immune system traits. It can contribute to personal knowledge and optimisation strategies without offering medical conclusions or disease diagnosis.

Use of the DNA Risk: HLA-Related Autoimmunity test aligns with broader goals of scientific curiosity and personal wellness exploration. The test fits well within health optimisation frameworks focused on understanding one's genetic makeup in a non-clinical context. It supports informed choices by providing detailed information about genetic markers while encouraging consultation with qualified healthcare professionals for any health-related decisions. The use of BloodSpot samples ensures sample quality and consistency for this purpose.

DNA Risk: HLA-Related Autoimmunity is intended for informational, educational, wellness and/or research purposes only. It is not intended for use in medical diagnosis, disease screening or clinical decision-making. DNA Risk: HLA-Related Autoimmunity is not a replacement for clinical laboratory testing and does not provide medical diagnoses. This content is intended for general information within the EU market and should not be interpreted as a regulated in-vitro diagnostic claim.